# Pharminho

> Pharmaceutical regulatory intelligence platform for drug approvals, regulatory guidance, compliance tools, and market insights.

Pharminho provides structured access to Indian and global pharmaceutical regulatory information, including CDSCO notifications, drug approval records, upcoming pipeline drugs, medical devices, biopharmaceutics classifications, and expert regulatory services.

## Public Resources

- [Home](https://www.pharminho.com/): Overview of Pharminho's pharmaceutical regulatory intelligence platform.
- [Drug Repository](https://www.pharminho.com/drug-repository): Searchable Indian drug database with approval statuses, notifications, and regulatory references.
- [Upcoming Drugs](https://www.pharminho.com/upcoming-drugs): Intelligence on upcoming drug approvals, CDSCO pipeline applications, and regulatory filing timelines.
- [Medical Devices](https://www.pharminho.com/medical-devices): Medical devices and in-vitro diagnostics database covering CDSCO classifications, licensure dates, and regulatory pathways.
- [Pharma Blog](https://www.pharminho.com/pharma-blog): Articles and insights covering pharmaceutical regulatory news, compliance guidance, and CDSCO updates.
- [BCS Classification](https://www.pharminho.com/bcs-classification): Biopharmaceutics Classification System (BCS) and BDDCS database covering solubility and permeability classifications for pharmaceutical molecules.

## Expert Regulatory Services

- [Custom Approval Pathway](https://www.pharminho.com/services/custom-approval-pathway): Customized CDSCO approval pathway guidance for New Drug, Generic, FDC, Import Registration or Notified Medical Product. 2,000 VCash.
- [Artwork Verification](https://www.pharminho.com/services/artwork-verification): Medicine artwork and labeling compliance check against the Drugs & Cosmetics Act, DMR requirements, and CDSCO directions. 1,000 VCash.
- [Competitor Information & Launch Timeline](https://www.pharminho.com/services/competitor-information-launch-timeline): Competitor intelligence and expected launch timelines covering regulatory pathways, clinical progress, and filing milestones. 3,000 VCash.
- [API Source Identification](https://www.pharminho.com/services/api-source-identification): Identification of compliant API manufacturers meeting quality and regulatory expectations for drug development. 1,500 VCash.
- [Detailed Costing](https://www.pharminho.com/services/detailed-costing): Projected expense assessment across the full drug approval process in India including government fees, BE/BA or clinical trial costs, and consulting. 1,500 VCash.
- [Detailed Market Research Reports](https://www.pharminho.com/services/detailed-market-research-reports): In-depth pharma market research reports covering approvals, formulations, indications, sales, and compliance requirements. 15,000 VCash.
- [Eligibility Check for BE Waiver](https://www.pharminho.com/services/eligibility-check-be-waiver): Bioequivalence waiver eligibility assessment under CDSCO criteria and NDCT Rules, based on BCS class, formulation and route. 2,000 VCash.
- [Eligibility Check for Clinical Trial Waiver](https://www.pharminho.com/services/eligibility-check-clinical-trial-waiver): Clinical trial waiver eligibility evaluation under CDSCO criteria and NDCT Rules, using safety data, global approvals, and literature. 2,000 VCash.
- [Global Approval Status](https://www.pharminho.com/services/global-approval-status): Consolidated drug approval status across USFDA, EMA, MHRA, TGA and other major global regulatory authorities. 500 VCash.
- [Other Queries](https://www.pharminho.com/services/other-queries): Expert guidance for additional regulatory compliance questions beyond standard services, including drug approvals, manufacturing licenses, and import regulations. 1,500 VCash.
- [Justification Note for BE Waiver](https://www.pharminho.com/services/justification-note-be-waiver): Detailed note outlining the scientific rationale, published literature, previous approvals, and regulatory grounds for Bioequivalence waiver in India. 3,000 VCash.
- [Justification Note for CT Waiver](https://www.pharminho.com/services/justification-note-ct-waiver): Comprehensive justification note detailing the scientific and regulatory basis for clinical trial waiver under CDSCO criteria. 3,000 VCash.
- [Patent Status](https://www.pharminho.com/services/patent-status): Check current patent status, validity and expiry timelines of any drug in India to assess freedom-to-operate and market entry. 5,000 VCash.
- [Personalized Regulatory Assessment](https://www.pharminho.com/services/personalized-regulatory-assessment): Tailored evaluation of applicable regulatory pathways, documentation needs, and compliance gaps for your specific drug product. 1,500 VCash.
- [Private Consulting Engagement](https://www.pharminho.com/services/private-consulting-engagement): 1-hour private consultation with experienced regulatory consultants on new drug approvals, manufacturing licenses, import regulations, and CDSCO compliance. 20,000 VCash.
- [Preparation of Therapeutic Rationale](https://www.pharminho.com/services/therapeutic-rationale-preparation): Comprehensive justification highlighting unmet medical need, mechanism of action, clinical benefits, and advantages over existing therapies. 3,000 VCash.
